ov3ryde – Page 23

ART adherence higher among youth in Africa than North America

Adolescents and young people (AYA) aged 12 – 24 in Africa and Asia are more likely to be adherent to antiretroviral therapy (ART) than their counterparts in North America and Europe, according to research published in AIDS this week. The study points to the fact that the HIV epidemics in North America and Europe are concentrated among key populations who are often marginalised from society, meaning they are hidden and have inadequate access to HIV services, such as treatment.

Are you open?  An exploration of open relationships

I have been fascinated with open relationships for more than 10 years. Africa is not traditionally monogamous and is no stranger to polyamory (loving more than one person at a time). Our own ‘prez’ has 4 wives and has been married six times. Initially I believed open relationships to be wrong, dangerous and not for me…

HPV

Syphilis

Celebrating Nurses Day: Stigma-free care for MSM

With the upscaling of South Africa’s HIV treatment programme necessitating task-shifting and the decentralisation of the South African healthcare system, nurses have become the backbone of public health, with most healthcare service centres being run entirely by nurses, with the support of visiting doctors.

To mark International Nurses Day on 12 May 2014, Anova is celebrating its nurses, and the work it does with nurses in the public health sector through its Health Systems Strengthening activities.

HIV Cure Research: Separating the Hope from the Hype

Sound science takes time. As Richard Jefferys of Treatment Action Group explained in a recent webinar, “HIV Cure Research—Getting Past the Media Hype,” a number of clinical trials are underway in the quest for an HIV cure, but none of the interventions currently under study are expected to cure people of HIV. Rather, those studies provide essential information to get cure science to “the next round” of development, said Jefferys.
Jefferys and webinar co-host David Evans, director of research advocacy at Project Inform and community advisory board member with the Delaney AIDS Research Enterprise, unpacked the concept of “cure,” outlined the types of cure currently under study, and highlighted key questions at the heart of cure research today.

Molecule in soy sauce might help fight HIV

HIV patients may soon get help from an unlikely source: a molecule used to enhance the flavors of soy sauce.

HIV infection increases risk of melanoma

HIV infection is associated with an increased risk of melanoma, according to the results of a meta-analysis published in PLOS ONE. Overall, people living with HIV had a 26% increase in their relative risk of melanoma compared to the general population, the risk increasing by 50% for white-skinned people with HIV. The increased risk was statistically significant in white-skinned people diagnosed with HIV and of borderline statistical significance for all people diagnosed with HIV.

Discovery of HIV Vulnerability Aids Vaccine Research

A team of scientists at The Scripps Research Institute (TSRI) working with the International AIDS Vaccine Initiative (IAVI) has discovered a new vulnerable site on the HIV virus. The newly identified site can be attacked by antibodies in a way that neutralizes a wide variety of HIV strains.

Tenofovir Alone May Work as Well as Truvada for Pre-exposure Prophylaxis

Tenofovir used as a single agent for pre-exposure prophylaxis (PrEP) may be as effective as the Truvada (tenofovir/emtricitabine) coformulation for preventing HIV infection, which, if confirmed, could have implications for cost and access worldwide.